These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6537079)

  • 21. Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort.
    Okamoto H; Terai C; Kamatani N
    BJU Int; 2004 Dec; 94(9):1401-2. PubMed ID: 15610133
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term outcome for lymph node-positive prostate cancer.
    Swanson GP; Riggs MW; Herman M
    Prostate Cancer Prostatic Dis; 2008; 11(2):198-202. PubMed ID: 17519924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
    Gaur S; Aish LS; Oo TH
    J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of stage A1 prostate cancer: the case for treatment.
    Bahnson RR
    Semin Urol; 1993 May; 11(2):54-7. PubMed ID: 7689739
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of locally advanced prostate cancer: new definitions and strategies.
    Roach M
    West J Med; 1998 Nov; 169(5):290-1. PubMed ID: 9830363
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lymphatic metastasis in prostatic carcinoma. Diagnostic value of staging and transcutaneous needle biopsy].
    Rothenberger K; Hofstetter A; Pfeifer KJ; Voeth C; Pensel J
    Fortschr Med; 1980 Sep; 98(34):1279-82. PubMed ID: 7461533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic carcinoma: efficacy of interstitial radiotherapy.
    Reddi RP
    J Kans Med Soc; 1982 Feb; 83(2):61-5, 82. PubMed ID: 7061913
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials referral resource. Prostate cancer.
    Cheson BD; Kaplan RS; Phillips PH
    Oncology (Williston Park); 1994 Dec; 8(12):35-6. PubMed ID: 7534101
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prostatic cancer: clinical situation and treatment strategy].
    Jacobi GH; Hohenfellner R
    Chirurg; 1981 Sep; 52(9):561-9. PubMed ID: 7297207
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate carcinoma II: prognostic factors in prostate needle biopsies.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G; Algaba F; Boccon-Gibod L
    BJU Int; 2006 Mar; 97(3):492-7. PubMed ID: 16469014
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nonepithelial tumors of the prostate].
    Galli L; Marcelli G
    Arch Ital Urol Nefrol; 1969; 42(6):465-77. PubMed ID: 5396291
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
    Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
    Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Lee WR; Pollack A; Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Paryani SB; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1413-8. PubMed ID: 11037556
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Orbital metastasis of prostatic cancer. Clinical and therapeutic aspects. Apropos of a case (clinical case)].
    Aubert J; Irani J; Saint-Blancat P
    Chirurgie; 1997 Jan; 121(9-10):672-5. PubMed ID: 9138330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic prostate cancer presenting as an asymptomatic neck mass.
    Carleton J; van der Riet P; Dahm P
    Prostate Cancer Prostatic Dis; 2005; 8(3):293-5; discussion 295. PubMed ID: 15897914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of prostatic cancer.
    Whitmore WF
    Prog Clin Biol Res; 1984; 153():447-54. PubMed ID: 6473407
    [No Abstract]   [Full Text] [Related]  

  • 38. Utilizing the tumor-node-metastasis staging for prostate cancer: the sixth edition, 2002.
    Chang SS; Amin MB
    CA Cancer J Clin; 2008; 58(1):54-9. PubMed ID: 18096866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of prostate cancer].
    Kan DV; Dunaevskiĭ IaL
    Urol Nefrol (Mosk); 1981; (4):29-34. PubMed ID: 7268980
    [No Abstract]   [Full Text] [Related]  

  • 40. [Screening for prostatic cancer].
    Pushkar' DIu; Govorov AV; Bormotin AV
    Urologiia; 2003; (1):10-5. PubMed ID: 12621959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.